The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions

Conclusions: Our results suggest that humoral immune response against TAAs is generated already during premalignant stages. Impact: Based on the obtained results, cancer-associated autoantibodies might make a valuable contribution to the stratification of high-risk patients with premalignant lesions in the stomach through enhancing the positive predictive power of existing risk models. Cancer Epidemiol Biomarkers Prev; 26(10); 1564–74. ©2017 AACR.

http://cebp.aacrjournals.org/cgi/content/short/26/10/1564?rss=1

Source: Cancer Epidemiology Biomarkers and Prevention - October 1, 2017 Category: Cancer & Oncology Authors: Meistere, I., Werner, S., Zayakin, P., Silina, K., Rulle, U., Pismennaja, A., Santare, D., Kikuste, I., Isajevs, S., Leja, M., Kupcinskas, L., Kupcinskas, J., Jonaitis, L., Wu, C.-Y., Brenner, H., Line, A., Kalnina, Z. Tags: Research Articles Source Type: research